Nano-X Imaging Ltd. (NNOX) is a Medical - Devices company in the Healthcare sector, currently trading at $2.47. It has a SharesGrow Score of 54/100, indicating a mixed investment profile with 3 out of 7 criteria passed.
Analyst consensus target is NNOX = $18 (+628.7% upside).
Valuation: NNOX trades at a trailing Price-to-Earnings (P/E) of -2.7 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.07.
Financials: revenue is $11M, +195.7%/yr average growth. Net income is $54M (loss), growing at -5.4%/yr. Net profit margin is -474.3% (negative). Gross margin is -94% (+22 pp trend).
Balance sheet: total debt is $7M against $189M equity (Debt-to-Equity (D/E) ratio 0.04, conservative). Current ratio is 5.63 (strong liquidity). Debt-to-assets is 3.5%. Total assets: $210M.
Analyst outlook: 4 / 5 analysts rate NNOX as buy (80%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 100/100 (Pass), Moat 15/100 (Fail), Future 94/100 (Pass), Income 10/100 (Fail).
